Matrixx considering partnership with other OTC companies to release Zicare and Xcid
SCOTTSDALE, Ariz. Matrixx Initiatives is exploring partnering with other over-the-counter companies on the national roll out of its Zicare oral care product and Xcid antacid.
“We continue to explore the possibility of partnering with other parties on both of those projects,,” Bill Hemelt, Matrixx acting president, CFO and COO, told analysts last week. “As we’ve said before, we don’t want to move forward on them by ourselves because of the significant risks associated with that,” he said. “Xcid was a disappointment. … We did roll it out on a limited basis this past year, but it did not meet our expectations. Not because it’s a bad product, it just simply will require greater investment to take that nationally. So we are exploring partnership possibilities for both of those projects.”
Both products are “market ready,” Hemelt said, replete with consumer research and product research.
Zicare, when used in conjunction with a daily oral routine, helps dissolve up to 30% of visible tartar that has already formed and helps inhibit future tartar formation above the gumline, according to the product web site. Zicare is a gel that is applied at the gumline and between the teeth after brushing and before bed.
Xcid is an antacid featuring a unique delivery form — a creamy pudding-like gel available in three flavors: strawberry, orange and chocolate.
McNeil launches new cause marketing campaign around Zyrtec to aid National Trust for Historic Preservation, WWF and ASPCA
FORT WASHINGTON, Pa. McNeil Consumer Healthcare on Thursday announced a new cause marketing campaign around Zyrtec.
For every eligible Zyrtec UPC code submitted online by June 30, McNeil has pledged a $2 donation to be shared among three charities — the National Trust for Historic Preservation, the World Wildlife Fund and the American Society for the Prevention of Cruelty to Animals — up to a total donation of $100,000 per organization.
The program was delivered exclusively via e-mail to members of McNeil’s Zyrtopia Web site, a Zyrtec-branded site that offers consumers information on allergies and daily pollen forecasts and creates a social media platform for allergy sufferers.
“Your participation will let the National Trust for Historic Preservation continue to save and revitalize America’s historic treasures, help the WWF preserve the diversity and abundance of life on Earth, and support the ASPCA in fighting animal cruelty,” McNeil’s e-mail stated.
Omega-3 linked to neural development of premature baby girls
CHICAGO Supplementing with omega-3 fatty acids may help in the neural development of premature baby girls, according to research published earlier this month in the Journal of the American Medical Association.
“A DHA [docosahexaenoic acid, an omega-3 fatty acid] dose of approximately 1% total fatty acids in early life did not increase [the Bayley Mental Development Index] scores of preterm infants overall born earlier than 33 weeks but did improve the MDI scores of girls,” researchers reported.
The MDI among girls fed the high-DHA diet was higher than girls fed standard DHA in unadjusted and adjusted analyses. The MDI among boys did not differ between groups.